Galactocerebroside

Europe PMC · fetched just now · sorted by publication date

1. 1
   Bioenergetic failure in diabetic peripheral neuropathy: from glucotoxicity to multidimensional metabolic imbalance.

   Tao W, Yu Y, Wu X, He J, Liu X, Huang J, Xiao F, Yu R. · 2026-06-24

   open access unreviewed
2. 2
   Galactose tolerance in adults with classical galactosaemia. Considering the gaps.

   Shakerdi LA, Thacker CN, Moore K, Sheerin A, Noga M, Rubio-Gozalbo ME, Berry GT, O'Byrne JJ, Saldova R, Treac… · 2026-02-26

   open access unreviewed
3. 3
   Testing an inverse link between limbic alpha-synucleinopathy and myelin markers in mice and humans.

   Clark RN, Landes RE, Abbas M, Mistretta VG, Jhaveri JR, DeLoatch KA, Franks J, Chen J, Luk KC, Hu X, Leak RK. · 2026-02-17

   open access unreviewed
4. 4
   Oligodendrocyte: Development, Plasticity, Biological Functions, Diseases, and Therapeutic Targets.

   Xiang Q, Shi RL, Huang YX, Liu LN, Tao JS, Li XH, Li XD. · 2026-02-08

   open access unreviewed
5. 5
   Plasma ECRG4 as a novel diagnostic marker for Alzheimer's disease associated with oligodendrocyte dysfunction.

   Zhang L, Ikeda N, Takeda S, Oikawa N, Murayama S, Koshimizu U, Yabe I, Kondo T. · 2026-05-15

   unreviewed
6. 6
   Sphingolipid metabolic enzyme GLA expression in gliomas: prognostic implications and therapeutic potential.

   Wei D, Su Q, Li X, Li H, Jin D, Pan Z, Yang M, Liu G, Du Y, Dong W. · 2026-03-24

   open access unreviewed
7. 7
   Immune dysregulation in <i>Mycoplasma pneumoniae</i> pneumonia: mechanistic controversies and clinical translation from inflammatory dysregulation and immune evasion to chronic injury.

   Li X, Wang Y, Wang Q, Wu H, Yan Y, Xiong Y, Ding Y. · 2026-02-25

   cited 1× open access unreviewed
8. 8
   Myelin Lipid Reserves as a Conditional Metabolic Buffer: Implications for Alzheimer's Disease and Ischemic Stroke.

   Zou P, Huang Z, Zhang Y, Zong X, Zhang Q. · 2026-01-30

   open access unreviewed
9. 9
   Molecular and functional characterization of GMP-manufactured neural stem cells and their extracellular vesicles for innovative therapeutic applications.

   Guzzetti M, Mezzasoma L, Chiasserini D, Macchioni L, Davidescu M, di Michele A, Gargaro M, Di-Iacovo N, Manni… · 2026-01-09

   open access unreviewed
10. 10
    IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

    Krijgsman D, Dijkxhoorn K, de Zeeuw E, Bloemenkamp LM, Bos JW, van Eijk RPA, Van de Walle I, Huizinga R, Jaco… · 2025-11-12

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.